Optipadin Eye Drops 0.2% (Olopatadine Hydrochloride) (Single-use)
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
IYON Pharma Co., Ltd.
MFDS item code 201309993 · Approved 2013.10.31 · Insurance code 658604041
Relief of symptoms of allergic conjunctivitis
Used to relieve symptoms such as itching, redness, and tearing in the eyes due to allergic conjunctivitis.
1 drop at a time, instilled once a day.
This medication should not be used in patients with allergic reactions to the active substance or other components. Using this medication may rarely cause neurological side effects such as headache or taste disturbances, and dizziness has also been reported. Regarding the eyes, rare side effects may include punctate keratitis, keratitis, eye pain, dryness, periorbital edema, itching, discharge, redness, changes in eyelid skin, discomfort, and very rarely, glare or blurred vision, or palpebral erythema. Dryness of the nose or rhinitis symptoms may rarely occur, and oral dryness or contact dermatitis has also been rarely reported. Fatigue may also be experienced not uncommonly. Furthermore, symptoms similar to a cold or pharyngitis may occur in about 10% of patients, with conjunctivitis or hypersensitivity, lethargy, low back pain, flu-like symptoms, frequent cough, infections, nausea, and sinusitis reported in some patients. This medication contains phosphate components, which may cause rare side effects such as corneal calcification in patients with severe corneal damage; caution is advised. It should not be used for irritation due to contact lens wear, and vision may temporarily become blurred after using the drops, so driving or operating machinery should be avoided until vision clears. There are no studies on interactions with other medications, so it is advisable to consult with a doctor or pharmacist about any concomitant medications. During pregnancy, it should only be used if deemed necessary due to potential risks to the fetus, and during breastfeeding, caution should be exercised considering the potential effects on the infant. It can be safely used in children over 3 years of age and shows similar safety in the elderly compared to adults. In case of overdose, immediate medical observation and management are necessary. For ophthalmic use only, care should be taken to avoid contact between the container and the eye or hands, and the cap should be tightly closed after use to prevent contamination. When using with other eye drops, at least a 5-minute interval should be observed, and ointments should be applied last. After opening, it should be used only once, and the first use should involve discarding 1-2 drops to remove container debris.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent air or moisture from entering. Additionally, it is important to store the medication at a cool temperature between 2°C and 25°C to maintain its effectiveness.
A colorless to pale yellow transparent liquid in a colorless transparent plastic container.
0.3mL × 12 vials
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
IYON Pharma Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.